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Perylene-3,4,9,10-tetra carboxylic diimide (PDI) has remarkable 
features as a photosensitizer in Photodynamic Therapy. However, PDI’s 
poor solubility in aqueous condition limits its use. So it is commonly 
functionalized by various substituents on imide positions where two 
nitrogen groups comprised with imide moiety. However, there has been 
a technical limitation to conjugate them with proper amine gorups such 
as amino acids or peptides having pi-electron system. To overcome this 
problem, solid-phase peptide synthesis (SPPS) method has been utilized 
to conjugate peptides having diverse pi-electron functional molecules. 
ii 
But still other problems appeared such as low yield with harsh reaction 
condition. Therefore, a new method was designed to overcome such 
disadvantages of conventional SPPS method. For this, reaction times, 
loading level, and solvent system were optimized. In this research, 
RGD sequence was conjugated as a substituent on imide position. The 
RGD sequence is well known as a cell attachment component. Thus, we 
could develope very useful materials which has both strong cell 
adhesion ability and photosensitizer for photodynamic therapy. 
 
Keywords: perylene-3,4,9,10-tetracarboxylic dianhydride, solid phase peptide 
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1. 1 Perylene-3,4,9,10-tetra carboxylic diimide 
 
Perylene-3,4,9,10-tetra carboxylic diimide (PDI) has remarkable 
features such as near-unity fluorescence quantum yields, high 
photochemical stability, and strong electron-accepting character.1-3 
Because of these unique features, PDI has attracted much attention in 
various fields such as organic photovoltaics, organic field-effect 
transistors, bio-labeling, sensors, single molecular spectroscopy, and 
supramolecular assemblies.4  
However, PDI’s poor solubility in aqueous condition limits its use in 
diverse fields. So it is commonly functionalized by various substituents 
on imide positions where two nitrogen groups comprised with imide 
moiety (Figure 1).5-6 Substitutions at the imide position does not 
disrupting the planar nature of the aromatic core. In fact, there have 
been many studies which provided enhancing PDI’s chemical and 





Fig 1. Various alkyl chains for introduced at the PDI imide position. 
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1. 2 Peptide-conjugated pi-electron material 
 
In bionanotechnology, supramolecular biomaterials with pi-electron 
functionality have shown high performance.4, 6, 8 Inspired by the self-
assembly in natural system, synthetic peptides have drawn great interest 
as a powerful tool of molecular self-assembly agents.8-10 Certain peptide 
amphiphiles have shown to exhibit sequence dependent self-assembly 
into well-defined structures such as, fibers, sheets, vesicles, micelles, 
and sacs (Figure 2).11 Theses self-assembled nanostructures have been 
explored for use as molecular encapsulation and delivery assembles, 
mineralization templates, magnetic resonance imaging contrast agents, 
and supported networks for regenerative medicine.12-15 
To obtain such functional materials, peptides were introduced by 
condensing with pi-electron material in molten imidazole.13 However, 
there is a technical limitation to conjugate proper peptide sequences 
with pi-electron material.14-15 For example, both the peptide amino 
terminus and the amine groups of side chain such as Lys can be 
involved in the condensation reaction, which produces undesired side 
products.16 To overcome this problem, solid-phase peptide synthesis 
(SPPS) method was utilized to conjugate diverse pi-electron functional 
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molecules with peptide (Figure 3). However, there are still other 
problems such as low yield with harsh reaction condition. Therefore, a 
new method was designed to overcome such disadvantages of 



























    Fig 3. Solid-phase peptide synthesis on Rink amide resin, using 







1. 3 Peptide-conjugated PDI for photodynamic therapy 
 
Photodynamic therapy (PDT) is an efficient treatment for various 
types of cancer. Living cell’s activities are easily suppressed by treating 
a photoactive molecule with molecular oxygen in the presence of light. 
Compared to other radiation therapy, PDT is nontoxic on the biological 
system.11-12, 15-17 Various kinds of photosensitizers were used in PDT, 
such as porphyrin, chlorins, bacteriochlorins, phthalocyanines, 
metallophthalocyanines, porphycenes, squaraines, cyanines. Some of 
these photosensitizers have been used in clinical field for cancer 
treatment.18-19 
PDI has many advantages in bioimaging and gene delivery because 
of high molar absorptivity, prominent chemical, thermal and 
photochemical stability. Also it has been utilized as a photosensitizer 
for generation of singlet oxygen (Figure 4).7, 10-11, 13 
To use PDIs for PDT, a tripeptide sequence, Arg-Gly-Asp (RGD), 
was introduced to PDI as a peptide ligand. The RGD sequence is well 
known as a cell attachment site in a number of adhesive extracellular 
matrix, and cell surface proteins, and nearly half of over 20 known 
integrins recognize this sequence as their adhesion ligands (Figure 5).7-8, 
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1. 4 Research Objective 
 
In this thesis, we developed new method to overcome such as low 
yield with harsh reaction condition while conjugating peptide with 
perylene by SPPS. New method was optimized with time, loading level 
and solvents. RGD sequence was conjugated as substituents on imide 
position. And RGD sequence is well known as a cell attachment. For 
this reason, we could make useful material which has both strong cell 
adhesion ability and photosensitizer for photodynamic therapy.
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2. Experimental Section 
 
2. 1 General 
 
Materials 
2-Chlorotrityl resin (100-200 mesh, 1.04 mmol/g), 1-
[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-
oxid hexafluorophosphate (HATU), 1-hydroxybenzotriazole (HOBt) 
anhydrous and filtered reactors (Libra tube) were purchased from 
BeadTech Inc. (Korea). Perylene-3,4,9,10-tetracarboxylic dianhydride 
from TCI (Japan), Ninhydrin, triisopropylsilane (TIPS), bovine serum 
albumin (BSA) and sodium cyanoborohydride were purchased from 
Sigma-Aldrich Co. (USA). Phenol was purchased from Junsei 
Chemical Co. Ltd. (Japan). Fmoc-Asp(otBu)-OH, Fmoc-Glycine-OH, 
Fmoc-Arg(pbf)-OH was purchased from BeadTech Inc. (Korea). 
Benzene, magnesium sulfate (MgSO4) anhydrous, hydrochloric acid 
(HCl), trifluoroacetic acid (TFA), tetrahydrofuran (THF), ethyl acetate 
(EA), methyl cyanide (MeCN), dichloromethane (DCM), N,N-
dimethylformamide (DMF), methanol (MeOH), ethanol (EtOH), acetic 
anhydride, N,N-diisopropylethylamine (DIPEA), piperidine, pyridine 
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and thionyl chloride were purchased from Daejung Chemicals & Metals 
Co. (Korea). Potassium cyanide (KCN) was purchased from DC 
Chemical Co. Ltd. (China). SPHEROTM Streptavidin coated fluorescent 




UV absorbance was measured by using Optizen 2120 UV 
(Mechasys, Korea). Fluorescent images were taken by using LSM 780 
confocal laser scanning microscope (Carl zeiss, Germany). Libra tubes 
were shaken by using SI-600R shaker (Jeio tech., Korea). Purity of 
synthesized peptide was analyzed by using LCQ LC/MS system 
(Thermo Finnigan, USA). 
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2. 2 Synthesis of L-alanine conjugated perylene dimide 
(PDI-[A]2) 
 
To synthesize PDI-[A]2 L-alanine (180 mg, 2 mmol) and perylene-
3,4,9,10-tetracarboxylic dianhydride (392 mg, 1 mmol) were mixed in 2 
g of imidazole. The mixed product was stirred for 30 min at 130 ℃ 
under nitrogen atmosphere. After 30 min, the temperature was lowered 
to 90 ℃ and 5ml of DW was added. After 10 min, the product was 
filtered to remove unreacted product.. Then, 1M of HCl (10 mL) was 
added to convert the ionized product into free acid form. Final product 
was centrifuged and washed with DW several times until the washings 















2. 3 Synthesis of PDI-[ARGD]2 by SPPS method 
 
2-CTC resin (1g, 1.04 mmol/g) was added into each of three fritted 
PE tubes to make different kinds of loading level. Fmoc-Asp(otBu)-OH 
(0.3, 0.6, 0.9 mmol) each and DIPEA (3 eq.) in 10ml (HPLC)-DMF 
was introduced to the 2-CTC resin containing fritted PE tubes. The 
reaction was proceeded for overnight. After the reaction, the remaining 
amino groups were capped by treating with 10ml MeOH and DIPEA (3 
eq.) for 3 hr. The Loading level was calculated by Fmoc titration. To 
conjugate the next amino acid, 10ml of 20% piperidine/DMF treated 20 
min that Fmoc groups were removed from the loaded resin. The rest 
amino acid was coupled with based on the loading level, HOBT (2 eq.) 
HBTU (2 eq.) Fmoc-Glycine-OH (2 eq.) and DIPEA (3 eq.) in 10ml 
DMF. For 3 hr in a shaking incubater, the resin was washed with DMF, 
DCM, MeOH 3 times each and Fmoc-Arg(pbf)-OH was conjugated by 
the same path. The resulting Fmoc-Arg(pbf)-Gly-Asp(tBu)-CTC resin 
was treated with 20% piperidine/DMF for 20 min and dried. Then, the 
resins were divided into four groups, 200mg each, to search for the 
optimal reaction times and loading levels. The deprotected H-Arg(pbf)-
Gly-Asp(tBu)-CTC resins were coupled to PDI-[A]2 with HOBT (1 eq.), 
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HBTU (1 eq.), DIPEA (1 eq.) and A-PDI-A (0.5 eq.) in DMF for 30 
min, 1 hr, 2 hr, 4 hr, 12 hr, respectively. The resin was washed with 
DMF, DCM, MeOH until there was no fluorescence from the washing 
solution. For on-bead dimerization, the same coupling condition, HOBT 
(1 eq.), HBTU (1 eq.), and DIPEA (1 eq.) in DMF, was applied. The 
dimerization time was same as previous reaction time. Final product 
was cleaved from the resin by treating resin with TFA/TIPS/H2O 
(95:2.5:2.5) solution for 1 hr and recovered as red solids by ether 
precipitation. The yield of product was compared with HPLC and ESI-
MS. To find out the swelling effect of resin on the synthesis, different 
kinds of solvents were also compared. DMF and two mixed solvents 
(THF/DMF, DCM/DMF) were used for SPPS. The loading level and 
the coupling reaction time were fixed 0.9 mmol/g and 2 hr. These 









2. 4 Reverse phase silica gel column chromatography 
 
After confirmed the structure of each peak by HPLC and ESI-MS, 
reverse phase silica gel column chromatography was used to obtain the 
final product. Fully end-capped C8-reversed phase silica gel was 
prepared and the reverse phase tlc plate was also used to get reasonable 
Rf value for separation. Under the 40:60 MeCN : H2O w/ 0.1% TFA 
solvent system, we could get 0.44 Rf value of product and 0.75 Rf 
value of by-product which peptide only conjugated one side of PDI. 
First of all, silica was flushed with distilled MeOH to pack. After 
loading sample on the sea sand, mobile solvent system was added for 
separation. higher pressure was generated than normal-phase flash 
chromatography and could see two different products was separated 
while coming down. The product earned by column chromatography 








2. 5 Cell preparation 
 
3T3 cell line was obtained from Sigma-aldrich. 3T3 cell line was 
grown in RPMI-1640 complete medium. The complete media for 3T3 
cell line was supplemented with 10% fetal bovine serum and 1% 
penicillin/streptomycine (Sigma-Aldrich). The cells were incubated at 
37 ℃ in a humidified atmosphere containing 5% CO2. The cells were 
seeded into 96-well plate. They were incubated overnight at 37 ℃ in a 
humidified atmosphere containing 5% CO2. Next day, they were 
washed with sterile PBS and incubated 2 hr with media which have 
only 1% penicillin/streptomycine at 37 ℃ in a containing 5% CO2. 
After 2 hr, they were washed with sterile PBS. Each cells were treated 
0.1mM, 0.01mM, 0.001mM, 0.0001mM of PDI-[ARGD]2 in 1% 









2. 6 Cell viability test 
 
3T3 cells were seeded (1×104 cells/well) onto 96-well plates, and 
incubated for 24hr. After replacing the culture medium with 200 μL of 
serum-free medium containing 0.1 mM, 0.01 mM, 0.001 mM, 0.0001 
mM of PDI-[ARGD]2, the treated cells were incubated for 2 hr at 37 ℃. 
The cells were washed with fresh medium and each well was treated 
with 20 μL of CCK-8 reagent and incubated for 2 hr. And then 














2. 7 Photodynamic therapy using PDI-[ARGD]2 and 
PDI-[A]2 
 
3T3 cells were seeded (1 ⅹ104 cells/well) on to 96-well plates, and 
incubated 24 hr. After replacing the culture medium with 200 uL of 
serum-free medium containing PDI-[ARGD]2 or PDI-[A]2 (each 
1mmol), the treated cells were incubated for 2 hr at 37 ℃. The cells 
were washed with fresh medium and irradiated with laser (535 nm, 
200nW/cm2, each well for 5 min). And then the cells were further 
incubated for another 3 hr to determine the phototoxicity. For dark-
toxicity, the cells were prepared following the same procedure without 
laser irradiation. At last, each well was treated with 20 uL of CCK-8 
reagent and incubated for 1 hr, and then absorbance was measured at 









3. Results and discussion 
 
3. 1 Synthesis of PDI-[A]2 
 
Scheme 1 shows how to synthesize A-PDI-A. First, 1 mmol of 
perylene-3,4,9,10-tetracarboxylic dianhydride and 2 mmol of L-alanine 
was stirred in molten imidazole at 130 ℃ for 30 minutes. Before 
finishing the reaction, the temperature was lowered to 90 ℃ and 5ml 
of DW was added. After 10 min of stirring, the product was filtered to 
remove unreacted product. And then 1M of HCl was treated to ionized 
product and washed with DW several times. Product was collected with 
filter glass and dried in vacuum oven 1 day. It was confirmed with 





























3. 2 Synthesis and characterization of PDI-[ARGD]2 
 
RGD sequence was coupled to PDI-[A]2 by SPPS method to afford 
PDI-[ARGD]2 (Scheme 2). Three different quantity of Fmoc-Asp(tBu)-
OH were coupled to CTC resin in DMF for overnight. After the loading 
level was calculated by Fmoc titration and Fmoc-Gly-OH, Fmoc-Arg-
(pbf)-OH were coupled to the Asp-CTC resin, sequentially. After all 
sequence was coupled to the resin, the time was optimized. Each of 
them were reacted with PDI-[A]2 30 min, 1 hr, 2 hr, 4 hr, 12 hr and 
dimerization was also proceeded at the same time (scheme 2). After 
reaction is finished, the color of resin formed dark-red with strong 
fluorescence under 365 nm (Figure 6a). The product cleaved from the 
resin also shows strong fluorescence of the same wavelength (Figure 
6b). Yield of product were compared using HPLC. The peak of 
monopeptide-PDI which is more hydrophobic than the dipeptide-PDI, 
around 15.2 min and that of dimerized product around 9.8 min, 
confirmed by ESI-MS (appendix). The yield of the product obtained by 
the integration of HPLC peaks is summarized (Figure 7). Increasing 
reaction time and high loading of peptide induced higher product yield. 
As expected, dimerization was affected by the density of the peptide 
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groups on CTC resin. Longer reaction time and higher loading gave 
good result of dimerized peptide-PDI conjugate resin. Various solvent 
system which can affect the swelling property of CTC resin were also 
compared (Table 1). DMF and two other mixed solvent system 
(THF/DMF, DCM/DMF) were used for SPPS. The loading level and 
reaction time were fixed 0.9 mmol/g and 2 hr, respectively. However, 
there was little difference of product yield with different kind of solvent 
system. It was expected that swelling property is direct factor for 
efficient synthesis of P-PDI bola-amphiphile due to controlling reaction 







































Fig 6a. Peptide conjugated PDI coupled resin showing strong 




Fig 6b. Peptide conjugated-PDI cleaved from CTC resin, showing 









Fig 7. Coupling and dimerization yield vs reaction time depending on 













Table 1 Swelling Property of CTC Resin and Dimerization Yield of P-





3. 3 Optical properties of PDI-[ARGD]2 
 
UV-Vis spectra of PDI-[ARGD]2 (Figure 8a) showed that three distinct 
absorption bands were emerged at 532, 490, and 460 nm in DMF-H2O 
mixture solvent. The highest observance was obtained at 532 nm. Upon 
addition of water, the absorption peak shifted to long wavelength and 
absorbance was decreased. This result suggest that PDI-[ARGD]2 could 
be used as photosensitizer in Photodynamic Therapy. Fluorescence 
spectra also showed similar tendency as UV-vis spectra (Figure 8b). 
When the ratio of water goes up in the DMF-H2O mixed solvent, 













Fig 8a. UV spectra of PDI-[ARGD]2 in DMF-H2O mixture of different ratios. 
 




3. 4 Cell toxicity test of PDI-[ARGD]2 on 3T3 cells 
 
3T3 cells were treated with PDI-[ARGD]2 (0.1 mM, 0.01 mM, 0.001 
mM, and 0.0001 mM) and incubated for 24 hr. After replacing the 
culture medium with fresh medium, each well was treated with 20 μL 
of Cell Counting Kit-8 (CCK-8) reagent, and incubated for 2 hr. Then 
the absorbance was measured at 450 nm to check cell viability (Figure 
9). CCK-8 allows sensitive colorimetric assays for the determination of 
cell viability in cell proliferation and cytotoxicity assays. The principle 

















































3. 5 Fluorescence image of 3T3 cell line 
 
To check the role of RGD sequence, PDI-[ARGD]2 was treated to 
3T3 cell lines. PDI-[A]2 was also treated to the 3T3 cell line as a control 
to compare the differences between the two. The 3T3 cells were 
incubated with both of the two fluorescence peptide conjugated 
materials were for overnight. After fixing the cells with formaldehyde, 
DAPI was used for dying the cell nucleus. The fluorescence image was 
obtained with confocal microscope (Figure 11). As can be seen from 
Fig 9a, PDI-[ARGD]2 showed strong fluorescence under 488 nm. On 
the other hand, PDI-[A]2 rarely responded with 488 nm and only 
showed DAPI fluorescence at nucleus. Confocal image of the cell 
showed that the fluorescence signal appeared from the inside of the cell. 









Fig 11. The fluorescence image of cells shows PDI-[ARGD]2 was well 
transported into the cell by endocytosis. This result indicate RGD 












3. 6 Photodynamic therapy with PDI-[ARGD]2 
 
3T3 cells were seeded and incubated for 24 hr. After replacing the 
culture medium with 200 uL of serum-free medium containing PDI-
[ARGD]2 or PDI-[A]2 (each 1mM), the treated cells were incubated for 
2 hr at 37 ℃. The cells were washed with fresh medium and irradiated 
with laser (535 nm, 200nW/cm2, each well for 5min). And then the cells 
were further incubated for another 3 hr to determine the phototoxicity. 
For dark-toxicity, the cells were prepared following the same procedure 
without laser irradiation. In dark-toxicity test, almost all the cells were 
survived in various concentration of PDI-[ARGD]2 and PDI-[A]2. After 
irradiating 535nm laser each, the cell viability after treating PDI-[A]2 
decreased but maintained as 85%. PDI-[ARGD]2 shows outstanding 
result that the cell viability was dramatically decreased to 45%. These 
results indicate that PDI-[ARGD]2 could be used in Photodynamic 









Figure 12. Almost cells were survived in non-light condition. 
However, after treating 535 nm laser to the cells for 5min, the cell 
viability of PDI-[A]2 was decreased 85% and PDI-[ARGD]2 was 











We designed a new method which can provide peptide conjugated 
perylene diimide (P-PDI) bola-amphiphile in more efficient way. By 
introducing a spacer amino acid, L-Ala, to perylene diimide (PDI) in 
molten imidazole, the solubility of perylene in organic solution was 
improved. Thus, the rest of the amino acid sequences can be conjugated 
to PDI-[A]2 via solid phase peptide synthesis method. A model peptide 
sequence, Arg-Gly-Asp (RGD), which can mediate cell attachment, 
was chosen for cell target therapy. We found that reaction time and 
loading level were critical factors for the synthesis of P-PDI bola-
amphiphile on CTC resin. Possibility of photodynamic therapy with 
PDI-[ARGD]2 was also tested on cells, and gave a good performance, 
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6. Abstract in Korea 
요     약 
 
퍼릴렌 테트라 카르복실릭 다이이미드는 다양한 특징을 
지니고 있고 광감각제로 광역학치료에 쓰인다는 연구가 있다. 
하지만 퍼릴렌 테트라 카르복실릭 다이안하이드라이드의 
수용액 상에서의 낮은 용해성 때문에 사용이 제한적이므로 
다이이미드 쪽에 치환기를 결합하여 실질적으로 활용되고 
있다. 기존 용액상에서의 원하는 펩타이드 시퀀스와의 결합은 
어려움이 있었고 이를 극복하기 위해 고체상 펩타이드 
합성법에 의한 결합이 고안되었다. 하지만 보고된 퍼릴렌 
테트라 카르복실릭 다이안하이드라이드와 고체상 합성법에 
의한 펩타이드 결합은 낮은 수율 및 까다로운 반응 조건이 
필요했다. 이를 극복하기 위해 새로운 방법이 고안되었고 높은 
수율을 통해 만든 물질을 합성 할 수 있었다. 퍼릴렌 
다이이미드에 아르기닌-글라이신-아스파틱 엑시드를 시퀀스를 
결합시켜 세포의 부착 성질을 부여하였고 퍼릴렌을 
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합성법, 광감각제, 광역학치료 
학번 : 2015-22838 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

